Market Signal Briefing

Taiwan Semiconductor Manufacturing Co. (TSMC) shares surged by the most since April, extending a powerful rally as investor optimism around artificial intelligence demand carried into the new year.

The world’s largest contract chipmaker climbed as much as 6.9% in Taipei trading to reach a fresh record high, underscoring its central role in the global AI supply chain.

The gains followed a bullish analyst move from Goldman Sachs Group Inc., which raised its price target on TSMC by 35% to NT$2,330.

The investment bank cited expectations of another year of solid growth, supported by improving profit margins and sustained demand for advanced chips used in AI computing.

Goldman upgrade fuels rally
Copy link to section

Goldman Sachs analysts, including Bruce Lu, said they remain confident in TSMC’s long-term growth prospects as AI investment accelerates globally.

“We view AI as a multi-year growth engine for TSMC,” the analysts wrote in a report.

Lu added that margins are improving even as the company plans to invest heavily in future capacity, projecting capital spending of $150 billion over the next three years.

The upgrade helped propel TSMC to the forefront of a broader advance in Asian technology stocks on Monday.

Investors continued to pour money into the AI theme despite concerns that valuations may be overheating.

According to market participants, fear of missing out on further gains outweighed worries about short-term volatility, even after recent geopolitical tensions following US strikes against Venezuela.

Technology shares once again provided the largest boost to regional equity benchmarks, reinforcing the sector’s dominance as AI-related companies attract incremental capital.

Asian chipmakers ride AI momentum
Copy link to section

TSMC’s rally came alongside continued strength in other major Asian chipmakers.

South Korea’s Samsung Electronics Co. extended its gains to a fifth consecutive session.

The memory chipmaker is expected to report preliminary results later this week, which investors will scrutinize for signs that earnings growth can justify the sector’s sharp run-up.

TSMC shares have climbed 44% in 2025, pushing the company’s market capitalization above $1 trillion for the first time.

The milestone reflects growing investor confidence in TSMC’s strategic position as the leading foundry for advanced chips, particularly those designed for artificial intelligence workloads.

“For leading-edge semiconductor, capacity from TSMC is the king,” Sanford C. Bernstein & Co. analysts including Mark Li, wrote in a note dated Friday.

This year “is still all about AI,” though the analysts urged investors to “focus on quality” amid concerns that parts of the market could be forming a bubble.

Advanced Chips Cement Strategic Role
Copy link to section

The company’s technological leadership has been reinforced by recent manufacturing progress.

TSMC last week began mass production of its 2-nanometre (N2) chips, a critical milestone in next-generation semiconductor development.

The company said the N2 technology, set to roll out in the fourth quarter of fiscal 2025, offers higher transistor density and improved energy efficiency, describing it as the most advanced semiconductor technology currently available.

TSMC supplies chips for a wide range of applications, from smartphones to high-performance servers.

Its customers include Nvidia Corp. and Apple Inc.

More than half of the world’s semiconductors, including nearly all high-end AI chips, are manufactured in Taiwan, positioning TSMC at the center of global supply chains.

Industry analysts view the 2nm ramp as a crucial step in helping TSMC maintain its technological edge and capture expanding AI-driven revenue opportunities in the years ahead.

A former top Chevron executive, Ali Moshiri, is raising $2 billion for Venezuelan oil projects after the U.S. captured its leader Nicolas Maduro and President Donald Trump said Washington would take control of the oil-producing nation, the Financial Times reported on Monday.

, /PRNewswire/ -- 

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the "Class Period") of the important January 26, 2026 lead plaintiff deadline.

So what: If you purchased Alexandria Real Estate Equities securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Alexandria Real Estate Equities class action, go to https://rosenlegal.com/submit-form/?case_id=48531 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants provided investors with material information concerning Alexandria Real Estate's expected revenue and funds from operations ("FFO") growth for the 2025 fiscal year, particularly as it related to the growth of Alexandria Real Estate's real estate operations. The defendants' statements included, among other things, confidence in Alexandria Real Estate Equities' lease activity, occupancy stability, and ability to develop its tenant pipeline.

According to the lawsuit, defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of its Long Island City ("LIC") property. In particular, Alexandria Real Estate's claims and confidence about the leasing value of the LIC property as a life-science destination. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Alexandria Real Estate Equities class action, go to https://rosenlegal.com/submit-form/?case_id=48531 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

HomeStock IdeasLong IdeasTech 

SummaryCleanSpark remains a Strong Buy despite recent stock volatility driven by Bitcoin price swings.CLSK trades at an 11.63x forward P/E (GAAP), a 63% discount to peers, highlighting significant undervaluation.The company's AI/HPC diversification is a long-term pivot, enhancing its strategic appeal beyond pure Bitcoin mining.With a $43,000 margin cost per Bitcoin, CLSK is well-positioned to weather potential crypto downturns. gorodenkoff/iStock via Getty Images

Since my previous coverage on CleanSpark (CLSK), the stock experienced a sharp downswing. Although weak AI sentiment clouds the AI/HPC pivot, in my opinion, the poor stock price action was mainly driven by Bitcoin volatility.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of CLSK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral antihypertensive therapy – the first systemic hypertension treatment to target a new pathway in over 30 years. Allschwil, Switzerland – January 5, 2026
Idorsia Ltd (SIX: IDIA) announces that Health Canada has granted marketing authorization for JERAYGO™ (aprocitentan) for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products.1 The recommended dose is 12.5 mg orally once daily. The dose can be increased to 25 mg once daily for patients tolerating the 12.5 mg dose and in need of tighter blood pressure (BP) control.1

Hypertension remains a leading global health challenge and the number one modifiable risk factor for early morbidity and mortality. Despite advances in treatment, many patients still struggle with uncontrolled blood pressure, leaving them at significantly higher risk of heart attack, stroke, kidney failure, and premature death.

Approximately 10% of hypertensive patients have resistant hypertension3,4 – defined by uncontrolled blood pressure despite receiving at least three antihypertensive medications from different classes, at optimal doses – underscoring the urgent need for more effective therapies.

Srishti Gupta, MD, Chief Executive Officer of Idorsia, commented:
“JERAYGO is the first and only hypertension treatment to target the endothelin pathway, a fundamental yet previously unaddressed driver of disease onset, progression, and complications. The results of PRECISION show that targeting the endothelin pathway is crucial to adequately manage uncontrolled blood pressure. JERAYGO has demonstrated rapid, durable, and clinically significant double-digit blood pressure reduction across a broad spectrum of challenging patient populations, including those with obesity, chronic kidney disease, or type 2 diabetes. I am very proud of our team for achieving this milestone.”

Idorsia is engaged in discussions to maximize the ability to make JERAYGO available to patients.

For more information on the marketing authorization of JERAYGO in Canada and important safety information, please review the Product Monograph.

Notes to the editor

About the Phase 3 PRECISION study1,5
The efficacy of aprocitentan was evaluated in one randomized, double-blind (DB), placebo-controlled Phase 3 multicenter study. Patients with uncontrolled blood pressure (systolic blood pressure [SBP] ≥140 mmHg) despite the use of at least three antihypertensive medicinal products and following exclusion of pseudo-resistant hypertension (e.g., white coat effect, inappropriate blood pressure measurement, secondary causes of hypertension) were considered to have resistant hypertension. The patients were switched to standardized background antihypertensive therapy consisting of an angiotensin receptor blocker (valsartan 160 mg), a calcium channel blocker (amlodipine 5 or 10 mg), and a diuretic (hydrochlorothiazide 25 mg) throughout the study. Patients with concomitant use of beta-blockers continued this treatment throughout the study, in addition to the standardized background antihypertensive therapy and study treatment. A total of 730 patients received either aprocitentan 12.5 mg, aprocitentan 25 mg, or placebo once daily during the initial 4-week DB treatment (part 1). Thereafter, patients received aprocitentan 25 mg once daily during the 32-week single-blind treatment (part 2). At the end of the 32 weeks, patients were re-randomized to receive either aprocitentan 25 mg or placebo, once daily, during the 12-week double-blind withdrawal (DB-WD) treatment (part 3).

The primary efficacy endpoint was the change in sitting SBP (SiSBP) from baseline to Week 4 during DB treatment (part 1), measured at trough by unattended automated office blood pressure (uAOBP). The key secondary endpoint was the change in SiSBP measured at trough by uAOBP from DB-WD baseline (Week 36) to Week 40 (part 3).

Patients had a mean age of 61.7 years (range 24 to 84 years; 34.1% were ≥ 65 and < 75 years; 9.9% were ≥ 75 years) and 59.5% were male. Patients were White (82.9%), African American (11.2%) or Asian (5.2%). The mean body weight was 97.6 kg (range 46 to 196 kg) and mean BMI was 33.7 kg/m2 (range 18 to 64 kg/m2). Patients had a medical history of type 2 diabetes mellitus (54.1%), ischemic heart disease (30.8%), central nervous system vascular disorders (23.0%), chronic kidney disease stages 3 and 4 (22.2%; 19.3% of patients had eGFR 30–59 mL/min/1.73 m2 and 2.9% had eGFR 15–29 mL/min/1.73 m2), congestive heart failure (19.6%), and sleep apnea syndrome (14.1%). 63.0% of patients had four or more antihypertensive medicinal products.

Key PRECISION findings1,5
Doses of aprocitentan 12.5 and 25 mg showed a statistically significant reduction vs placebo on SiSBP at Week 4. The treatment effect was consistent for sitting diastolic blood pressure (SiDBP). The persistence of the BP-lowering effect of aprocitentan was shown in DB-WD treatment (part 3). In patients re-randomized to placebo, the mean SiSBP increased, whereas in patients re-randomized to aprocitentan 25 mg the mean effect on SiSBP was stable, resulting in a statistically significant difference. The treatment effect was consistent for SiDBP. The effect was also consistent across SBP and DBP measured by ambulatory BP monitoring (ABPM) and assessed as daytime, night-time, and 24h periods at Week 4 and Week 40. A substantial proportion (i.e., at least 90%) of the BP-lowering effect was observed within the first two weeks of treatment with aprocitentan. The effect of aprocitentan was consistent across subgroups of age (including patients ≥ 75 years), sex, race (including patients with Black or African American origin), BMI, baseline urine albumin-to-creatinine ratio (UACR), baseline eGFR and medical history of diabetes.

The most frequently reported adverse reactions with aprocitentan were edema/fluid retention (mostly peripheral edema) (9.1%, 12.5 mg; 18.4%, 25 mg) and hemoglobin decreased (3.7%, 12.5 mg; 1.2%, 25 mg).

JERAYGO is contraindicated for use in women who are pregnant, breast-feeding, in women of childbearing potential who are not using reliable contraception, patients with severe hepatic impairment, and in patients with hypersensitivity to the active substance or to any of the excipients.

About aprocitentan
Aprocitentan is Idorsia’s once-daily, orally active, dual endothelin receptor antagonist, which inhibits the binding of ET-1 to ETA and ETB receptors. Aprocitentan is approved as TRYVIO™ in the US for the treatment of systemic hypertension in combination with other antihypertensives and has been commercially available since October 2024. Aprocitentan is approved as JERAYGO™ for the treatment of resistant hypertension in combination with at least three antihypertensives in the European Union, the UK, and Switzerland, and now in Canada.

Idorsia Pharmaceuticals Ltd has transferred its rights for aprocitentan (including JERAYGO™) to Idorsia Investments SARL to allow the repayment of notes issued in connection with the repurchase offer completed in August 2025. More details on the transfer can be found in the press release issued on May 21, 2025 and on the exchange offer in the press release issued on August 27, 2025.

References

JERAYGO™ Product MonographNCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398:957-80.Noubiap JJ, et al. Global prevalence of resistant hypertension: a meta-analysis of data from 3·2 million patients. Heart 2019; 105: 98–105.Williams B, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021–104.Schlaich MP, et al. A randomized controlled trial of the dual endothelin antagonist aprocitentan for resistant hypertension. The Lancet, 2022; Dec 3;400(10367):1927-1937. About Idorsia
The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most. To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners – and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core.

Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ™ (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients. Idorsia is listed on the SIX Swiss Exchange (ticker symbol: IDIA).

For further information, please contact:
Investor & Media Relations
Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, CH-4123 Allschwil
+41 58 844 10 10
[email protected] – [email protected] – www.idorsia.com

The above information contains certain "forward-looking statements", relating to the company's business, which can be identified by the use of forward-looking terminology such as “intend”, "estimates", "believes", "expects", "may", "are expected to", "will", "will continue", "should", "would be", "seeks", "pending" or "anticipates" or similar expressions, or by discussions of strategy, plans or intentions. Such statements include descriptions of the company's investment and research and development programs, business development activities and anticipated expenditures in connection therewith, descriptions of new products expected to be introduced by the company and anticipated customer demand for such products and products in the company's existing portfolio. Such statements reflect the current views of the company with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements of the company to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected.

Press Release PDF

January 05, 2026 01:00 ET

 | Source:

SEALSQ

Geneva, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) --

SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that its C-suite leadership, led by its Founder and Chief Executive Officer Carlos Moreira, will conduct a strategic roadshow across India in early January to accelerate the establishment of a post-quantum semiconductor personalization center and to advance collaboration on post-quantum satellite initiatives with WISeSat.Space.

The roadshow, which will take place from January 5-9, 2026, with visits to Mumbai, Ahmedabad, New Delhi, Hyderabad, and Bangalore, includes high-level meetings, industrial site visits, and strategic discussions with key partners across India’s leading innovation, semiconductor, and space hubs.

A central focus of this initiative is the strengthening of long-term industrial partnerships, in particular with Kaynes Semicon and Skyroot Aerospace, as part of SEALSQ’s strategy to bring its advanced quantum and post-quantum technologies to the Indian market. SEALSQ aims to leverage trusted local distributors and industrial partners to ensure sustainable and scalable market coverage.

In parallel, the SEALSQ delegation will meet with leading Indian quantum startups and research-driven ventures, with the objective of making strategic investments through its dedicated $100 million Quantum Fund. This fund is designed to support breakthrough technologies across quantum computing, post-quantum cryptography, quantum AI, and secure semiconductor architectures, fostering a resilient and sovereign quantum ecosystem.

India is rapidly emerging as a major global force in quantum technologies, driven by the government-led National Quantum Mission (NQM). The country’s dynamic startup ecosystem includes companies such as QpiAI, which has recently achieved key milestones with the launch of its 25-qubit QpiAI-Indus system and the 64-qubit Kaveri quantum chip. By integrating artificial intelligence with quantum computing and building a fully domestic quantum stack, India is positioning itself for utility-scale quantum advantage across healthcare, finance, materials science, and critical infrastructure.

The roadshow underscores the strategic importance of the Swiss–India relationship, reinforced by the Trade and Economic Partnership Agreement (TEPA) between India and the EFTA States (Iceland, Liechtenstein, Norway, and Switzerland). TEPA enhances legal certainty and long-term plannability for bilateral trade while significantly improving access for Swiss goods and services to the Indian market. Together these factors create a robust framework for technology transfer and industrial cooperation.

In parallel, SEALSQ and WISeSat are working on the possibility of launching WISeSat satellites from India during 2026, within WISeSat’s sovereign constellation model. This initiative aims to reinforce technological sovereignty, secure connectivity, and space cooperation, while aligning with India’s rapidly expanding launch and space manufacturing capabilities.

“India is a key strategic partner for our long-term vision in quantum security, advanced semiconductors, and sovereign space infrastructure,” said Carlos Moreira, Founder and CEO of SEALSQ. “This roadshow marks an important milestone in deepening our collaboration with India’s quantum, semiconductor, and space ecosystems. By aligning industrial deployment, strategic investment, and shared technological sovereignty, we aim to build resilient, future-ready capabilities that support secure digital infrastructure, next-generation connectivity, and trusted global supply chains.”

About SEALSQ:
SEALSQ is a leading innovator in Post-Quantum Technology hardware and software solutions. Our technology seamlessly integrates Semiconductors, PKI (Public Key Infrastructure), and Provisioning Services, with a strategic emphasis on developing state-of-the-art Quantum Resistant Cryptography and Semiconductors designed to address the urgent security challenges posed by quantum computing. As quantum computers advance, traditional cryptographic methods like RSA and Elliptic Curve Cryptography (ECC) are increasingly vulnerable.

SEALSQ is pioneering the development of Post-Quantum Semiconductors that provide robust, future-proof protection for sensitive data across a wide range of applications, including Multi-Factor Authentication tokens, Smart Energy, Medical and Healthcare Systems, Defense, IT Network Infrastructure, Automotive, and Industrial Automation and Control Systems. By embedding Post-Quantum Cryptography into our semiconductor solutions, SEALSQ ensures that organizations stay protected against quantum threats. Our products are engineered to safeguard critical systems, enhancing resilience and security across diverse industries.

For more information on our Post-Quantum Semiconductors and security solutions, please visit www.sealsq.com.

Forward-Looking Statements
This communication expressly or implicitly contains certain forward-looking statements concerning SEALSQ Corp and its businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include SEALSQ's ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; and the risks discussed in SEALSQ's filings with the SEC. Risks and uncertainties are further described in reports filed by SEALSQ with the SEC.

SEALSQ Corp is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

SEALSQ Corp.
Carlos Moreira
Chairman & CEO
Tel: +41 22 594 3000
[email protected] Investor Relations (US)
The Equity Group Inc.
Lena Cati
Tel: +1 212 836-9611
[email protected]

Oil markets are reacting to Venezuela's political shock, but OPEC and Gulf officials warn that expectations for quick supply gains are premature amid deep uncertainties. CNBC's Dan Murphy tells us more.

Honda Motor said on Monday it will extend a production halt at three car plants in China by two weeks due to a semiconductor shortage, highlighting persistent supply chain strains for Japan's second-biggest automaker.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Skip to the content

Home Altcoins News BitMine Requests Share Increase to Support Ethereum Growth Strategy

dan saada

January 5, 2026

BitMine Immersion Technologies has proposed a significant increase in its authorized shares, asking shareholders to approve the move. Led by Chairman Tom Lee, the company aims to enhance its flexibility for future stock splits, which are expected as the firm’s share price rises alongside its primary treasury asset, Ethereum (ETH). A vote on this proposal is scheduled for January 14.

On January 2, Lee addressed investors concerning Proposal 2, which would raise BitMine’s authorized common stock from 500 million to 50 billion shares. He reassured stakeholders that the proposal does not imply imminent shareholder dilution. Rather, the increase is intended to facilitate strategic capital raises, enable potential mergers, and allow for future share splits. “The last point is key,” Lee stated, noting the necessity of having a sufficient number of authorized shares to accommodate splits.

This initiative is closely tied to BitMine’s strategic shift in mid-2025, when the company prioritized Ethereum as its main treasury asset. The stock price of BitMine now closely mirrors ETH’s value. Recently, the company acquired 32,938 ETH for $97.6 million on December 31, 2025. This acquisition brought its total Ethereum holdings to approximately 4.07 million ETH, valued at around $12 billion.

Lee’s strategy hinges on a positive long-term outlook for Ethereum. Citing institutional confidence in tokenization—echoed by figures like BlackRock’s Larry Fink—Lee believes most tokenization will occur on the Ethereum network. He projects potential ETH prices of $22,000, $62,000, or even $250,000 if Bitcoin reaches $1 million. Given BitMine’s stock price correlation with ETH, potential scenarios suggest share prices could be $500, $1,500, or $5,000. To maintain share accessibility for retail investors, Lee plans to split the stock to lower the price to about $25, necessitating the proposed increase in authorized shares.

This strategic move comes as Ethereum experiences a challenging period. Data indicates 2025 was its toughest year since 2018, with nine monthly losses leading to a 12% annual decline. ETH is currently trading slightly above $3,000, a 3.5% increase in the last 24 hours, but remains 39% below its all-time high in August 2025. Despite these challenges, Lee and BitMine continue to build their treasury, anticipating an eventual rebound attributed to Ethereum’s expected role in the financial sector.

Shareholders will soon decide on the proposed increase in authorized shares, a step that could significantly shape BitMine’s future in alignment with its Ethereum-focused strategy.

Post Views: 12

dan saada

Dan hold a master of finance from the ISEG (France) , Dan is also a Fan of cryptocurrencies and mining.
Send a tip to: 0x4C6D67705aF449f0C0102D4C7C693ad4A64926e9

Crypto newsletter
Get the latest Crypto & Blockchain News in your inbox.

Bitcoin price started a major increase above $91,200. BTC is now showing bullish signs and might extend gains above $93,000.

Bitcoin started a fresh increase above the $91,200 zone.
The price is trading above $92,000 and the 100 hourly Simple moving average.
There is a key bullish trend line forming with support at $91,500 on the hourly chart of the BTC/USD pair (data feed from Kraken).
The pair might continue to move up if it stays above the $91,200 zone.

Bitcoin Price Eyes More Upsides
Bitcoin price remained supported above the $90,000 zone and started a fresh increase. BTC gained pace for a move above the $90,500 and $91,200 resistance levels.

It even surpassed $92,000. A new multi-week high was formed at $93,333 and the price is now consolidating gains. It is stable above the 23.6% Fib retracement level of the recent upward move from the $90,804 swing low to the $93,333 high.

Bitcoin is now trading above $92,000 and the 100 hourly Simple moving average. Besides, there is a key bullish trend line forming with support at $91,500 on the hourly chart of the BTC/USD pair.

If the price remains stable above $91,500, it could attempt a fresh recovery wave. Immediate resistance is near the $93,200 level. The first key resistance is near the $93,500 level. The next resistance could be $94,000. A close above the $94,000 resistance might send the price further higher.

Source: BTCUSD on TradingView.com
In the stated case, the price could rise and test the $94,650 resistance. Any more gains might send the price toward the $95,000 level. The next barrier for the bulls could be $95,500 and $95,800.

Another Decline In BTC?
If Bitcoin fails to rise above the $93,200 resistance zone, it could start another decline. Immediate support is near the $92,200 level. The first major support is near the $92,000 level or the 50% Fib retracement level of the recent upward move from the $90,804 swing low to the $93,333 high.

The next support is now near the $91,500 zone. Any more losses might send the price toward the $90,500 support in the near term. The main support sits at $90,000, below which BTC might accelerate lower in the near term.

Technical indicators:

Hourly MACD – The MACD is now gaining pace in the bullish zone.

Hourly RSI (Relative Strength Index) – The RSI for BTC/USD is now above the 50 level.

Major Support Levels – $92,000, followed by $91,500.

Major Resistance Levels – $93,200 and $94,000.

XRP Scan – Active Users – 050126
XRP Outlook Bullish
Strong demand for XRP-spot ETFs reaffirmed the bullish short-term (1-4 weeks) outlook, with a $2.5 price target. Meanwhile, rising utility, a dovish Fed policy stance, and the Senate passing the Market Structure Bill reinforce the positive longer-term price paths:

Medium-term (4-8 weeks): $3.0.
Longer-term (8-12 weeks): $3.66.

Key Risks Challenge Bullish Outlook
Several scenarios could unravel the positive outlook. These include:

The Bank of Japan declares a neutral interest rate in the range of 1.5% and 2.5%, indicating multiple rate hikes. A higher neutral would narrow US-Japan rate differentials and trigger a yen carry trade unwind.
US economic data and the Fed are lowering bets on a March rate cut.
The MSCI delists digital asset treasury companies (DATs). Delistings are likely to temper interest in XRP as a treasury reserve asset.
Lawmakers oppose the Market Structure Bill.
XRP-spot ETFs report outflows.

These scenarios would likely send the token toward $1.75, indicating a bearish trend reversal.

Technical Indicators Continue to Signal Caution
XRP advanced 3.59% on Sunday, January 4, following the previous day’s 0.60% gain, closing at $2.0908. The token outperformed the broader crypto market cap, which climbed 1.06%.

Sunday’s breakout sent XRP above its 50-day EMA, while remaining below the 200-day Exponential Moving Averages (EMAs). The EMAs indicated a bullish near-term but bearish longer-term price outlook. While technicals sent mixed signals, bullish fundamentals are building, outweighing the bearish longer-term technical structure.

Key technical levels to watch include:

Support levels: $2.0, $1.75, and then $1.50.
50-day EMA resistance: $2.0468.
200-day EMA resistance: $2.3458.
Resistance levels: $2.5, $3.0, and $3.66.

Looking at the daily chart, holding above the 50-day EMA would affirm a near-term bullish trend reversal, paving the way toward the 200-day EMA and the $2.5 resistance level.

A break above the EMAs would reinforce the bullish medium-term outlook and the longer-term (8-12 weeks) $3.66 price target.

Ethereum price started a steady upward move above $3,050. ETH is now consolidating gains and might aim for more gains above $3,200.

Ethereum started a fresh increase above $3,000 and $3,050.
The price is trading above $3,100 and the 100-hourly Simple Moving Average.
There is a short-term bullish trend line forming with support at $3,120 on the hourly chart of ETH/USD (data feed via Kraken).
The pair could continue to move up if it clears the $3,200 zone.

Ethereum Price Eyes More Gains
Ethereum price started a fresh increase after it settled above the $3,000 zone, like Bitcoin. ETH price gained pace for a move above the $3,050 and $3,120 resistance levels.

The bulls even pumped the price toward $3,200. A high was formed at $3,218, and the price is now consolidating gains. It declined a few points below the 23.6% Fib retracement level of the recent increase from the $3,116 swing low to the $3,218 high.

Ethereum price is now trading above $3,100 and the 100-hourly Simple Moving Average. Besides, there is a short-term bullish trend line forming with support at $3,120 on the hourly chart of ETH/USD.

If the bulls are able to protect more losses below $3,120, the price could attempt another increase. Immediate resistance is seen near the $3,200 level. The first key resistance is near the $3,220 level. The next major resistance is near the $3,250 level.

Source: ETHUSD on TradingView.com
A clear move above the $3,250 resistance might send the price toward the $3,350 resistance. An upside break above the $3,350 region might call for more gains in the coming days. In the stated case, Ether could rise toward the $3,450 resistance zone or even $3,500 in the near term.

Another Decline In ETH?
If Ethereum fails to clear the $3,220 resistance, it could start a fresh decline. Initial support on the downside is near the $3,165 level or the 50% Fib retracement level of the recent increase from the $3,116 swing low to the $3,218 high.

The first major support sits near the $3,120 zone. A clear move below the $3,120 support might push the price toward the $3,050 support. Any more losses might send the price toward the $3,000 region.

Technical Indicators

Hourly MACD – The MACD for ETH/USD is gaining momentum in the bullish zone.

Hourly RSI – The RSI for ETH/USD is now above the 50 zone.

Major Support Level – $3,120

Major Resistance Level – $3,220

Stablecoin transfer volume on Ethereum surpassed $8 trillion in the fourth quarter of 2025, marking a new all-time high, reported Token Terminal on Monday.

The $8 trillion milestone is almost double the transfer volume figure for the second quarter, which was just over $4 trillion, according to the chart.

Stablecoin issuance on Ethereum increased by around 43% in 2025 from $127 billion to $181 billion by year’s end, according to BlockWorks.  

“This isn’t speculation. This is global payments happening on-chain,” commented “BMNR Bullz” on X. This is before SWIFT-style integrations, full RWA tokenization, and institutional rails going live. “The rails are already built. Adoption is catching up,” they added. 

Stablecoin volumes on Ethereum surged in Q4. Source: Token TerminalEthereum transactions and addresses peakThe milestone coincided with an all-time high in total daily transactions on the Ethereum (ETH) network, which hit 2.23 million in late December, according to Etherscan. Ethereum daily transactions are currently up 48% since the same time last year. 

Token Terminal reports that Ethereum active monthly addresses hit an all-time high of 10.4 million in December. 

Monthly active addresses peaked in December. Source: Token TerminalThere was also an increase in the daily number of unique addresses that were active on the network as senders or receivers, which topped a million in late December.

Ethereum remains king for RWA tokenizationThe Ethereum network remains the primary settlement layer for stablecoins and real-world asset tokenization, with around 65% market share of total RWA on-chain value, which is around $19 billion, according to RWA.xyz.

That market dominance increases to over 70% when layer-2 and EVM networks are included. 

Ethereum currently has a 57% market share of all stablecoins issued, with the Tron network in second place with a 27% share.

Tether (USDT) remains the market leader in issuance with $187 billion, equating to 60% of the entire stablecoin market, and more than half of that is on Ethereum. 

Magazine: Kain Warwick loses $50K ETH bet, Bitmine’s ‘1000x’ share plan: Hodler’s Digest

In brief
Meme coins Pepe, Bonk, and Shiba Inu led a speculative charge, with double-digit gains, as Bitcoin pushed above $90,000.
Macro factors like rate cuts could fuel a "risk-on" 2026, but some have warned meme coin rallies are poor signals due to low liquidity.
Market sentiment remains split, with prediction market optimism at a 2026 high while the broader Crypto Fear & Greed Index stays in "Fear."
Meme coins are surging amid renewed interest in the sector, as Bitcoin continues to grind higher for the start of the year.

Leading the charge are Bonk, Pepe, and Shiba Inu, posting 24-hour gains of over 20%, 14%, and 10%, respectively, according to CoinGecko data. On a weekly basis, however, Pepe leads with a 70% rally, followed by Bonk at 48% and Dogecoin at 22%.

The resurgence in crypto's riskier assets coincides with a stabilizing Bitcoin.

The top crypto has closed higher for four consecutive days, pushing past the pivotal $90,000 mark after several failed attempts in late 2025.

Bitcoin’s drive this time, however, is backed by a substantial uptick in the aggregated open interest, which has surged to $31.44 billion, a six-week high, according to CryptoQuant.

Sustained rate-cutting cycle, disinflation, and new U.S. access to strategic resources like Venezuelan oil as factors that could be coalescing to support risk assets, according to Derek Lim, head of research at crypto market-making firm Caladan.

“All the above when viewed in tandem may prelude to a shift towards a more risk-on sentiment in 2026,” Lim told Decrypt. “Perhaps the current price movements are attempting to price all these in.”

He urged caution, however, in interpreting the meme coin rally as a definitive signal. 

“I will hesitate to read this as the market shifting into a more risk-on mode,” Lim said. “Meme coin pumps can be relatively easily manufactured by a multitude of factors, such as low liquidity, extremely low float, so it may not necessarily represent any larger shifts in momentum/attitudes with regard to the broader market.”

Retail sentiment mirrors that cautiously optimistic stance.

Users on prediction market Myriad—owned by Decrypt’s parent company, Dastan—now assign an 82% chance that Bitcoin hits $100,000 before $69,000, up from 62% at the start of the year.

The recovery is not limited to meme coins; other top altcoins, including Hyperliquid, Hedera, Aster, and XRP, have also surged by roughly 5% over 24 hours. 

Still, the Crypto Fear & Greed Index suggests that, despite the hot streak in meme coins, the broader psychological recovery from the 2025 downturn is not yet complete.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

The new year meme coin frenzy continued on Sunday as major coins extended their gains.

New Year Festivities Continue For MemecoinsSolana (CRYPTO: SOL)-based dogwifhat (CRYPTO: WIF) lifted over 17% in the last 24 hours. Trading volume for the dog-themed cryptocurrency jumped 132% to $450 million, signaling high trading interest and buying pressure.

Pepe (CRYPTO: PEPE) and Bonk (CRYPTO: BONK) led the gains among memecoins with a market capitalization exceeding $1 billion, rallying 17% and 14%, respectively.

These two coins also ranked as the second and third-largest gainers across the entire market in the past 24 hours.

Cryptocurrency24-Hour Gains +/-Price (Recorded at 9:30 p.m. ET)Dogwifhat+17.17%$0.4032Pepe
               +14.50%$0.000007106Bonk+13.67%$0.00001191Shiba Inu+8.54%$0.000008959See Also: Dogecoin (DOGE) Price Prediction 2025, 2026, 2030

Market Leaders RiseMeme heavyweight Shiba Inu (CRYPTO: SHIB) popped over 8% as top wallets of the cryptocurrency continued to accumulate. As of this writing, the ten largest addresses held nearly 63% of the supply, according to Santiment.

Similarly, Dogecoin (CRYPTO: DOGE) rose nearly 2% in the last 24 hours

The overall memecoin market capitalization increased by 5.72% in the last 24 hours to $47.75 billion, a level not seen in nearly two months. The total trade volume increased by 50% to $8.83 billion in the last 24 hours.

Memecoin bulls would hope that the New Year surge leads to long-term gains for the sector following a dismal 2025.

Read Next: 

Disappointed By Bitcoin And Dogecoin In 2025? These Coins Soared Over 2000% To Dominate The Gainers List
Photo Courtesy: Dennis Diatel on Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

XRP price started a strong increase above $2.00. The price is now consolidating gains and might aim for more gains above the $2.165 zone.

XRP price started a fresh increase above the $2.00 zone.
The price is now trading above $2.10 and the 100-hourly Simple Moving Average.
There is a bullish trend line forming with support at $2.070 on the hourly chart of the XRP/USD pair (data source from Kraken).
The pair could continue to move up if it settles above $2.20.

XRP Price Regains Traction
XRP price started a decent upward move above $2.00 and $2.020, like Bitcoin and Ethereum. The price gained pace for a clear move above the $2.10 resistance.

The bulls even pumped the price above the $2.150 zone. A high was formed at $2.165 and the price started a consolidation phase above the 23.6% Fib retracement level of the upward move from the $1.983 swing low to the $2.165 high.

The price is now trading above $2.10 and the 100-hourly Simple Moving Average. Besides, there is a bullish trend line forming with support at $2.070 on the hourly chart of the XRP/USD pair.

Source: XRPUSD on TradingView.com
If there is a fresh upward move, the price might face resistance near the $2.1650 level. The first major resistance is near the $2.180 level, above which the price could rise and test $2.20. A clear move above the $2.20 resistance might send the price toward the $2.250 resistance. Any more gains might send the price toward the $2.320 resistance. The next major hurdle for the bulls might be near $2.350.

Downside Correction?
If XRP fails to clear the $2.1650 resistance zone, it could start a fresh decline. Initial support on the downside is near the $2.120 level. The next major support is near the $2.070 level or the 50% Fib retracement level of the upward move from the $1.983 swing low to the $2.165 high.

If there is a downside break and a close below the $2.070 level, the price might continue to decline toward $2.020. The next major support sits near the $2.00 zone, below which the price could continue lower toward $1.9650.

Technical Indicators

Hourly MACD – The MACD for XRP/USD is now gaining pace in the bullish zone.

Hourly RSI (Relative Strength Index) – The RSI for XRP/USD is now above the 50 level.

Major Support Levels – $2.10 and $2.070.

Major Resistance Levels – $2.1650 and $2.20.

Crypto Reporter

Shalini Nagarajan

Crypto Reporter

Shalini Nagarajan

Part of the Team Since

Jan 2024

About Author

Shalini is a crypto reporter who provides in-depth reports on daily developments and regulatory shifts in the cryptocurrency sector.

Has Also Written

Last updated: 

January 4, 2026

Bitcoin snapped back above $92,000 on Monday as Asian markets opened the first full trading week of 2026, with equities advancing and oil trading unevenly after a dramatic US operation in Venezuela reset global risk calculations.

The recovery in crypto came as investors weighed the implications of Washington’s move to seize control of the oil-rich nation.

Market snapshot
Bitcoin: $92,947, up 1.2%
Ether: $3,163, up 0.4%
XRP: $2.12, up 3.1%
Total crypto market cap: $3.23 trillion, up 0.9%
President Donald Trump said over the weekend that the US had placed Venezuela under temporary American control, following the capture of President Nicolás Maduro.

US authorities said Maduro and his wife, Cilia Flores, were flown to New York and charged with narco-terrorism conspiracy and other crimes. An indictment alleged that drug trafficking had enriched and entrenched Venezuela’s political and military elite.

Oil Retreats As Traders Gauge Supply Fallout From Venezuela CrisisThe sudden escalation rattled energy markets early in the session. Brent crude slid more than 1% at one point before trimming losses, and was last trading about 0.25% lower.

West Texas Intermediate fell roughly 0.4% as traders assessed how the intervention could disrupt supply from a country that holds the world’s largest proven crude reserves.

Oil drops as traders weigh the fallout from the capture of Venezuelan President Nicolás Maduro by US forces on global crude supply https://t.co/yZNmHhTKM2

— Bloomberg (@business) January 4, 2026
Venezuela, a founding member of OPEC, accounts for about 303B barrels of oil, roughly 17% of global reserves, according to US Energy Information Administration data, a reminder of why oil prices reacted swiftly to the news.

Regional Stocks Strengthen As Japan Rebounds And Risk Appetite FirmsAsia-Pacific equities, however, leaned into risk. MSCI’s broad index of shares outside Japan climbed about 1.2%, while S&P 500 e-mini futures edged 0.1% higher, signalling a cautiously positive handoff to Wall Street.

Japan led regional gains, with the Nikkei surging 2.8% and moving back toward a record high reached two months ago. The rally followed data showing factory activity stabilised in December, snapping five months of contraction.

Elsewhere, South Korea’s Kospi and Taiwan’s benchmark rose more than 2% each to fresh record highs. Hong Kong stocks were more subdued, up 0.1%, weighed down by oil majors after a gauge of energy shares slid 3.1%. Australian shares added a modest 0.1%.

Crypto Upswing Builds As ETFs Attract Fresh CapitalCrypto traders viewed the geopolitical shock through a different lens. The market’s rebound reflected a renewed bid for alternative assets as investors repositioned around risk.

Akshat Siddhant, lead quant analyst at Mudrex, said the broader trend in digital assets had turned decisively higher following the developments in Venezuela.

“The rally is supported by a strong return of institutional interest, with crypto ETFs recording about $646M in net inflows on the first trading day of the year after December’s heavy selling,” he said.

“Sentiment is also improving, as the Fear-Greed Index turned neutral for the first time since October. Currently trading near $92,800, if BTC closes above $93,700, momentum could carry it toward $100,000, with support forming near $88,500.”

Follow us on Google News

Bitcoin briefly hits $93,000 as crypto market extends new year rally with $260 million in liquidationsThe rally in crypto was mirrored by a surge in commodities and Asian equities, driven by AI-led momentum and geopolitical developments.Updated Jan 5, 2026, 4:55 a.m. Published Jan 5, 2026, 4:45 a.m.

Bitcoin BTC$92,563.04 briefly touched $93,000 on Monday as traders leaned into a fresh risk bid across markets following a U.S. ousting of Venezuela, while year-opening flows pushed major tokens higher after a choppy finish to 2025.

BTC traded up about 1% over 24 hours and roughly 3% over seven days, while ether held near $3,160, also higher on the day. XRP added around 3% to above $2.10, extending its early January outperformance, while Solana hovered near $136. Dogecoin eased on the day but remained up 17% over the past week, the highest gains among majors.

STORY CONTINUES BELOW

Derivatives positioning amplified the move. Liquidations crossed $260 million over 24 hours, with shorts accounting for about $200 million, showing late sellers were forced to cover as prices pushed higher.

The rally came alongside strength in risk assets and another surge in commodities. Asian equities climbed to a record as investors piled into technology shares, extending last year’s AI-led momentum. Brent crude steadied after early weakness tied to the Venezuela developments, while gold jumped sharply back above $4,400 an ounce and silver posted an even larger move.

Traders said the start-of-year bid reflects a mix of positioning and relative value, with crypto still far below its peaks while other assets sit near records.

“We believe that in the new year, traders are jumping in to exploit price inefficiencies,” Jeff Mei, chief operating officer at BTSE, said in a Telegram message, noting cryptocurrencies remain well off their all-time highs as equities and precious metals keep printing new records.

A move in markets began over the weekend as the U.S. took Venezuelan president Nicolás Maduro was into custody, with Donald Trump signaling a

He also suggested U.S. troops on the ground would not be necessary as long as acting Venezuelan president Delcy Rodríguez “does what we want.”

More For You

KuCoin Hits Record Market Share as 2025 Volumes Outpace Crypto Market

Dec 22, 2025

KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.

What to know:

KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.View Full Report

More For You

Asia Morning Briefing: Data shows legacy media took a more balanced view of bitcoin in 2025

3 hours ago

Media attention shifted from bitcoin’s environmental footprint to crime and kidnapping in 2025, while overall sentiment remained broadly neutral, according to crypto intelligence platform Perception.

What to know:

In 2025, mainstream media coverage of Bitcoin became more balanced, with neutral reporting surpassing negative stories.The shift in narrative was driven by the exhaustion of earlier critiques rather than increased enthusiasm for Bitcoin.AI emerged as the dominant topic in media, overshadowing Bitcoin and driving more significant sentiment swings.Read full story

Exchange balances are at multi-year lows, signaling potential supply tightness that could amplify future rallies.Updated Jan 5, 2026, 5:25 a.m. Published Jan 5, 2026, 5:24 a.m.

XRP pushed above $2.12 as buyers forced a break through a stubborn resistance area on above-average volume, with the move landing at a time when exchange balances are sitting near multi-year lows and U.S.-listed spot ETFs continue to absorb supply — a mix that traders often read as supportive for follow-through if the breakout holds.

News backgroundInstitutional demand for regulated XRP exposure has stayed constructive, with U.S.-listed spot XRP ETFs adding $13.59 million in fresh inflows earlier this week. That flow profile has mattered because it’s been steady rather than headline-driven, helping absorb supply during periods when spot price action has been choppy.

STORY CONTINUES BELOW

At the same time, exchange balances have continued to trend lower, a dynamic traders often frame as a “supply tightness” signal — not a guarantee of upside, but a condition that can amplify rallies when demand picks up. XRP’s market cap rose to about $121.7 billion on the session, underscoring the scale of participation behind the move.

On the network side, activity has been improving, with XRP Ledger transaction counts climbing back toward the 1 million daily mark. That tends to reinforce the narrative that demand isn’t purely speculative, even if price action remains the key driver in the short term.

Technical analysisXRP rose 2.04% to $2.12, breaking through the $2.10–$2.12 ceiling that had capped recent rebound attempts. The breakout came with volume running 47.6% above the seven-day average, a key confirmation signal because resistance breaks that happen on light participation often fail quickly.

After the initial push, XRP shifted into a tight consolidation band between $2.128 and $2.152, with repeated tests of $2.128 holding as short-term support. That’s the level traders will likely treat as the “line in the sand” for whether the move is building a base or turning into a quick rejection.

The structure is constructive: price is consolidating above former resistance, rather than immediately falling back into the prior range. Still, the next upside leg likely needs fresh participation — volume tapered after the surge, suggesting the market is waiting for either a broader risk-on push or another catalyst.

The key overhead area now sits around $2.15–$2.16, which is the next supply pocket inside the broader $2.06–$2.16 range. A clean push through that zone typically brings $2.20 into play quickly, while a failure that loses $2.128 risks a slide back toward the lower range boundary.

Price action summaryXRP gained 2.04% to $2.12, outperforming broader markets by ~180 bpsVolume ran 47.6% above the weekly norm, supporting the breakoutPrice consolidated in a $2.128–$2.152 band after the initial pushThe breakout held above former resistance, keeping upside structure intactWhat traders should knowThis trade is increasingly about structure + supply conditions.

If $2.128 holds: XRP is building a post-breakout base, and the next test is $2.15–$2.16. A clean break there shifts focus to $2.20–$2.28, where sellers have previously shown up.If $2.128 fails: the breakout risks reverting into the prior range, with downside pullback targets near $2.06 and then the range floor.Why the move matters: ETF inflows + shrinking exchange supply can make rallies sharper when they start. That doesn’t remove overhead supply, but it raises the odds that resistance breaks can extend faster than traders expect once stops trigger and momentum players step in.Net: XRP has done the hard part by clearing $2.12 with volume. The next signal is whether it can hold above $2.12–$2.13 on retests — that’s what separates continuation from another “poke-and-fade.”

More For You

KuCoin Hits Record Market Share as 2025 Volumes Outpace Crypto Market

Dec 22, 2025

KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.

What to know:

KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.View Full Report

More For You

Bitcoin eyes longest daily winning streak in 3 months

5 minutes ago

Bitcoin rose over 1% during Monday's Asian trading session, marking a potential five-day winning streak.

What to know:

Bitcoin rose over 1% during Monday's Asian trading session, marking a potential five-day winning streak.The broader crypto market, including major cryptocurrencies like XRP, solana, and ether, also saw gains of up to 1%.Tax-loss selling has subsided, one analyst said explaining the upswing, while others attributed the uptick to haven demand.Read full story

Bitcoin rose over 1% during Monday's Asian trading session, marking a potential five-day winning streak. Jan 5, 2026, 5:28 a.m.

Bitcoin BTC$92,645.14 climbed over 1% during Monday's Asian trading session, positioning itself for a five-day winning streak, the longest since early October.

The leading cryptocurrency by market value jumped from roughly $91,480 to $92,500, CoinDesk data show. At one point, prices topped $93,000. Major alternative cryptocurrencies such as XRP$2.1333, solana SOL$135.82, and ether ETH$3,164.35 jumped 0.7% to 1%. The CoinDesk 20 and CoinDesk 80 Indexes rose 1.5%, pointing to a broader market cheer.

STORY CONTINUES BELOW

"Market sentiment is improving, with both Bitcoin and Ethereum transitioning into bullish trend regimes," Markus Thielen, founder of 10x Research, who was recently voted as the top crypto analyst, said in a Telegram message to CoinDesk.

"We turned constructive following the late-December options expiry, anticipating that tax-loss selling would subside and that trading desks would regain flexibility to deploy risk into the new year," Thielen added.

BTC's daily gain/loss in percentage terms. (TradingView)

Bitcoin and the wider crypto market mostly remained depressed through December as U.S.-based holders supposedly liquidated their holdings at a loss to offset capital gains and reduce overall tax liability. Investors intentionally realize losses on underperforming assets to lower the tax owed on profitable sales.

Bitcoin underperformed Nasdaq, gold, and other precious metals through 2025, ending the year with a 6% loss. The performance was particularly weak during the North American trading hours in the final weeks of the year.

Bitcoin's latest uptick coincides with renewed geopolitical stress from the U.S. capture of Venezuelan President Nicolás Maduro. This rise is increasingly viewed as a sign of cryptocurrencies attracting safe-haven demand.

"We view the simultaneous surge across multiple asset classes following U.S. military action in Venezuela as a textbook flight to quality. Safe havens such as gold and silver are rallying sharply as investors price in elevated geopolitical risk that could persist or escalate," Ryan Lee, chief analyst at cryptocurency exchange Bitget, said in an email.

"Oil, for now, remains relatively contained around the $60 per barrel level, which helps limit immediate inflation pressure, but markets are clearly discounting the risk of future energy disruptions and tighter liquidity conditions that may compel the Federal Reserve to keep rates elevated for longer," Lee added.

Looking ahead, the bias remains bullish while BTC's price holds above the 21-day exponential moving average, according to Thielen.

"Early ETF inflows have been encouraging, and as long as Bitcoin holds above its 21-day moving average, the near-term bias remains skewed to the upside," Thielen said.

The 11 bitcoin spot exchange-traded funds (ETFs) pulled in over $471 million on Friday, the largest single-day tally since Nov. 11, according to data source SoSoValue.

More For You

KuCoin Hits Record Market Share as 2025 Volumes Outpace Crypto Market

Dec 22, 2025

KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.

What to know:

KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.View Full Report

More For You

XRP breaks $2.12 as shrinking exchange supply lead to price squeeze higher

8 minutes ago

Exchange balances are at multi-year lows, signaling potential supply tightness that could amplify future rallies.

What to know:

XRP surged past $2.12, breaking a key resistance level with above-average trading volume.Institutional demand remains strong, with U.S.-listed spot XRP ETFs seeing $13.59 million in new inflows this week.Exchange balances are at multi-year lows, signaling potential supply tightness that could amplify future rallies.Read full story

Nvidia has been one of the market's biggest winners in recent years, but this success has also led to a high valuation.

Nvidia (NVDA +1.26%) just finished up another great year. The stock rose 39% in 2025 and looking at recent earnings reports, for the first three quarters of its 2026 fiscal year (the nine-month period ending Oct. 26, 2025), the chipmaker's revenue increased 62% year over year. Gross profit increased 48%, and net income increased 52%.

Expectations are high for this year, especially after management revealed an order backlog of $500 billion through the end of 2026. However, Nvidia is trading at an expensive 46 times trailing earnings. With that in mind, should you buy Nvidia stock now or wait for a cheaper opportunity?

Image source: Nvidia.

How to buy Nvidia shares
There's a lot to like about Nvidia as an investment. Nvidia's graphics processing units (GPUs) are in high demand from other AI companies, which is the primary reason its revenue has exploded. Data center revenue made up 90% of Nvidia's total revenue in its most recent quarter. It's certainly a quality company to have in your portfolio, particularly if you're looking for top AI stocks. Excellent companies often trade at high valuations, so you shouldn't let its price-to-earnings ratio (P/E) dissuade you from investing.

That said, it's normal to question how much more Nvidia can grow if there is a pullback in the near future. It's the largest public company by market cap as I write this, and the valuation is high, although reasonable compared to most AI companies. For perspective, competitor Advanced Micro Devices trades at 106 times trailing earnings, making Nvidia look like a bargain in comparison.

Today's Change

(

1.26

%) $

2.35

Current Price

$

188.85

If you're concerned about investing too heavily in Nvidia all at once, dollar-cost averaging is a good alternative. This mans buying a fixed amount of Nvidia stock on a schedule that works for you. For example, you could purchase one or two shares each week no matter what the stock is doing. 

I've dollar-cost averaged into many tech stocks I like, Nvidia included. It's a useful strategy for volatile stocks because even if the share price declines, you'll have the opportunity to buy the dip.

Lyle Daly has positions in Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia. The Motley Fool has a disclosure policy.

, /PRNewswire/ -- WuXi Biologics (2269.HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized standard that integrates sustainability principles into procurement practices and promotes transparency and responsibility across the supply chain. This recognition highlights WuXi Biologics' outstanding performance in sustainability and showcases the company's dedicated efforts in strengthening supply chain resilience.

Dr. Chris Chen, WuXi Biologics CEO and Chairman of the ESG Committee, commented, "As a member and active participant of PSCI*, WuXi Biologics adheres to world-leading management strategies to build a robust supply chain that ultimately serves as the value chain empowering sustainable business growth. We deliver high-quality solutions to meet global client demands while making active contributions that spearhead responsible value chain advancement in the pharmaceutical industry."

Supplier Lifecycle Management

WuXi Biologics has embedded sustainability principles across its entire system of supplier lifecycle management — from supplier due diligence and admission, to risk management and engagement, to performance review and termination. This not only ensures that suppliers consistently meet quality, compliance, and sustainability standards throughout their partnerships, but also enables transparent and traceable supply chains, mitigates risks, improves operational efficiency, and drives responsible practices among suppliers.

Net-Zero Across Value Chain

Deeply understanding the importance of tackling climate change, WuXi Biologics has adopted an integrated strategy with measurable SBTi targets and refined roadmaps. While diligently pursuing its own climate goals, the company also actively engages with suppliers through comprehensive sustainable supply chain management to help achieve positive impacts across the entire value chain.

As a participant of the United Nations Global Compact (UNGC), WuXi Biologics proactively advocates sustainability and has earned widespread recognitions for its efforts. The company was granted an MSCI AAA Rating; awarded an EcoVadis Platinum Medal; listed in the Dow Jones Sustainability Indices (DJSI); named to the CDP "A List" for Climate Change, Water Security, Supplier Engagement Assessment; given the highest negligible-risk rating by Sustainalytics, and recognized as a Sustainalytics industry and regional ESG top-rated company for five consecutive years; selected as a Constituent of the FTSE4Good Index Series; listed in the Hang Seng ESG 50 Index; and rated as Prime by ISS ESG Corporate Rating.

*PSCI: Pharmaceutical Supply Chain Initiative, the leading association for pharmaceutical and healthcare companies with a common vision of excellence in safety, environmental, and social outcomes across the global healthcare value chain.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of June 30, 2025, WuXi Biologics is supporting 864 integrated client projects, including 24 in commercial manufacturing.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives green technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while consistently achieving excellence in Environment, Social and Governance (ESG). Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

SOURCE WuXi Biologics

The arrest of Nicolás Maduro has thrown one of the world's most politically fraught oil industries back into focus, forcing investors to reassess who controls Venezuela's crude resources and whether they can be meaningfully revived after decades of decline.

For now, the answer may seem straightforward. "Petróleos de Venezuela (PDVSA), the state-owned oil company, controls the majority of the oil production and reserves," said Andy Lipow, president of Lipow Oil Associates. 

American energy corporation Chevron operates in the country through its own production and a joint venture with PDVSA, while Russian and Chinese firms also participate through partnerships, though "majority control is still with PDVSA," Lipow said. 

If Trump is successful in seeing a more pro-U.S. and pro-investment government take shape in Venezuela, Chevron is best placed [to control Venezuelan oil] given the are already well positioned there.

Saul Kavonic

MST Financial

Venezuela nationalized its oil industry in the 1970s, which led to the creation of PDVSA. Oil output peaked at about 3.5 million barrels per day in 1997, but has since plunged to an estimated 950,000 barrels per day, with around 550,000 barrels per day exported, data provided by Lipow Oil Associates showed.

If a more pro-U.S. and pro-investment government takes shape in Venezuela, Chevron would be "best placed" to expand its role, said Saul Kavonic, head of energy research at MST Financial. European companies like Repsol and Eni could also benefit, given their existing positions in Venezuela, he said.

What it means for global oilAny regime change could disrupt the commercial chain that keeps Venezuelan barrels flowing, industry experts warned.

"Since it is unclear at this time who is in charge in Venezuela, we might see exports completely halt as the buyers don't know to whom to send the money," said Lipow. He added that the latest round of U.S. sanctions on a shadow fleet of tankers has severely affected exports, forcing Venezuela to cut production.

The shadow fleet refers to tankers that operate outside traditional shipping, insurance and regulatory systems to move crude from sanctioned countries. These vessels are commonly used to transport oil from nations such as Venezuela, Russia and Iran, which face U.S. restrictions on energy exports.

Lipow expects Chevron to continue exporting 150,000 barrels per day, limiting any immediate supply impact. Still, he said the broader uncertainty could add a short-term risk premium of about $3 per barrel.

That bump would come against a market that many analysts see as adequately supplied, at least for now. "The oil market currently is trending towards oversupply," Rapidan Energy Group's Bob McNally said, calling the immediate impact "almost a nothing burger."

Venezuela's longer-term importance lies in the type of oil it produces. The country's heavy, sour crude can be technically challenging to extract, but prized by complex refineries, particularly in the U.S. "American refineries... love to slurp that gunky oil from Venezuela and Canada," McNally said.

"The real issues are, will the oil industry be able to get back into Venezuela and reverse two decades of dilapidation and neglect and get it back up?"

If a new government led by opposition leader Maria Corina Machado is installed very quickly, sanctions could ease and oil exports could initially rise as stored oil is used to generate revenue, Lipow said. However, a short-term surge could pressure prices, he added.

Stock Chart IconStock chart icon

Oil prices in the past one year

Still, any notion of a sustained recovery faces hard physical limits. "The Venezuelan oil industry is in such a state of disrepair that even with a change in government, it is unlikely to see any material increase in oil production for years as substantial investments are required to rehabilitate the existing infrastructure," he noted.

Similarly, RBC's Helima Croft warned that the path to recovery is long, citing Venezuela's "decades-long decline under the Chávez and Maduro regimes." She said that oil executives contend it will cost at least $10 billion annually to turn the sector around, with "a stable security environment" an absolute prerequisite.

"All bets are off in a chaotic change of power scenario like what occurred in Libya or Iraq," she said.

— CNBC's Chery Kang and Martin Soong contributed to this report.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.